Answer
Dupilumab (Dupixent) is indicated for chronic spontaneous urticaria in patients aged 12 years and older whose disease is not adequately controlled with H1 antihistamine treatment.
Sources for this answer
- Dupixent 300 mg solution for injection in pre-filled syringeSANOFI · emc · SmPC §4.1 Therapeutic Indications · Version 27Document updated
Sources checked